American Society for Bone and Mineral Research (ASBMR) Educational Resource focus on Osteoporosis

A ten lesson course with scientific reviews in e-learning format. You will have access to the latest developments in the care of patients with osteoporosis both in the study of the disease and in the management of patients in their clinical practice.

This program is sponsored by Stada and has the scientific endorsement of the SEIOMM (Spanish Society for Bone Research and Mineral Metabolism).

Upon completing the course, you will be able to summarize the latest developments in research and development on mineral homeostasis, osteoporosis, and other metabolic bone diseases, including skeletal and genetic measurement technologies.

Dates: 01/04/2024 – 31/03/2025

Credits have been requested from the Spanish National Health System 
(20 class hours) – Nº 09/039815-MD

Lesson 1: Influence of age on the efficacy of pharmacologic treatments on fracture risk reduction and increases in BMD: RCT results from the FNIH-ASBMR-SABRE project (2h)
05/05/25

Lesson 2: Simultaneous automated ascertainment of prevalent vertebral fracture and abdominal aortic calcification in clinical practice: role in fracture risk assessment (2h)
05/05/25

Lesson 3: Defining the key clinician skills and attributes for competency in managing patients with osteoporosis and fragility fractures (2h) 
09/06/25

Lesson 4: Following hip fracture, hospital organizational factors associated with prescription of anti-osteoporosis medication on discharge, to address imminent refracture risk: a record-linkage study (2h)
09/06/25

Lesson 5: Complex clinical encounter series: osteoporosis presenting during pregnancy and lactation: wait and reassess (2h)
07/07/25

Lesson 6: High physical activity is associated with greater cortical bone size, better physical function, and with lower risk of incident fractures independently of clinical risk factors in older women from the SUPERB study (2h)
07/07/25

Lesson 7: Femoral neck width genetic risk score is a novel independent risk factor for hip fractures (2h)
01/09/25

Lesson 8: Oral daily PTH(1-34) tablets (EB613) in postmenopausal women with low BMD or osteoporosis: a randomized, placebo-controlled, 6-month, phase 2 study (2h)
06/10/25

Lesson 9: Treating osteoporosis in patients with atypical femoral fracture (2h)
03/11/25

Lesson 10: Association of vertebral fractures with worsening degenerative changes of the spine: a longitudinal study (2h)
01/12/25